Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

TransMedics Group, Inc. (TMDX) Profit Margins

Over the twelve months to 2026-06-30, TransMedics Group, Inc. (TMDX) had gross margin 58.7%, operating margin 12.2%, net margin 22.7%, free cash flow margin 11.8%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

TMDXTransMedics Group, Inc.Follow TMDX — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
2.5B
P/E TTM
—
Dividend yield
0.0%
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin58.7%64.9%69.9%69.8%63.8%59.4%59.9%58.7%
Operating margin-125.4%-102.9%-130.3%-33.6%-11.9%8.5%17.9%12.2%
Net margin-142.1%-112.1%-146.1%-38.8%-10.4%8.0%31.4%22.7%
FCF margin-137.5%-119.8%-107.0%-61.8%-68.2%-18.3%22.1%11.8%

USD billions · SEC XBRL

TransMedics Group, Inc. — questions

What is TransMedics Group, Inc.'s gross margin?
58.7% over the twelve months to 2026-06-30.
What is TransMedics Group, Inc.'s operating margin?
12.2% over the twelve months to 2026-06-30.
What is TransMedics Group, Inc.'s net profit margin?
22.7% over the twelve months to 2026-06-30.

Every figure on this page comes from TransMedics Group, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.